Adjuvant chemotherapy for breast cancer: Effects on cerebral white matter seen in diffusion tensor imaging

被引:106
作者
Abraham, Jame [1 ]
Haut, Marc W. [2 ,3 ,4 ]
Moran, Maria T. [2 ,4 ]
Filburn, Shannon [1 ]
Lemiuex, Susan [4 ,5 ]
Kuwabara, Hiroto [6 ]
机构
[1] Johns Hopkins Univ, Dept Med, Sect Hematol & Oncol, Baltimore, MD USA
[2] Johns Hopkins Univ, Dept Behav Med & Psychiat, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Dept Radiol, Baltimore, MD 21218 USA
[5] W Virginia Univ, Sch Med, Ctr Adv Imaging, Morgantown, WV 26506 USA
[6] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA
关键词
antiestrogen therapy; cyclophosphamide; doxorubicin; fractional anisotropy;
D O I
10.3816/CBC.2008.n.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The purpose of this study was to examine the effect of adjuvant chemotherapy on normal-appearing white matter in women with breast cancer. Patients and Methods: Ten patients with early-stage breast cancer who were treated with adjuvant chemotherapy and 9 age-, education-, and IQ-matched healthy controls were studied with magnetic resonance imaging. Diffusion tensor imaging was used to calculate fractional anisotropy (FA), a measure of white matter integrity. Measurements were made in the genu and splenium of the corpus callosum. Participants also completed measures of processing speed, depression, and anxiety. Results: Relative to controls, patients had slower processing speed and lower FA in the genu. Processing speed was positively correlated with FA in the genu. Conclusion: The results of this pilot study suggest that adjuvant chemotherapy affects normal-appearing white matter in the genu of the corpus callosum and that this is related to the cognitive deficits experienced by patients.
引用
收藏
页码:88 / 91
页数:4
相关论文
共 27 条
[1]   Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma [J].
Ahles, TA ;
Saykin, AJ ;
Furstenberg, CT ;
Cole, B ;
Mott, LA ;
Skalla, K ;
Whedon, MB ;
Bivens, S ;
Mitchell, T ;
Greenberg, ER ;
Silberfarb, PM .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) :485-493
[2]   Lifelong endocrine fluctuations and related cognitive disorders [J].
Ancelin, ML ;
Ritchie, K .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (32) :4229-4252
[3]  
Beck A.T., 1993, BECK DEPRESSION INVE
[4]  
Beck A. T., 1993, Beck Anxiety Inventory (BAI): Technical Manual
[5]  
Brown MS, 1998, AM J NEURORADIOL, V19, P217
[6]  
BROWN MS, 1995, AM J NEURORADIOL, V16, P2013
[7]  
Buzdar AU, 1999, SEMIN ONCOL, V26, P21
[8]   Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen [J].
Castellon, SA ;
Ganz, PA ;
Bower, JE ;
Petersen, L ;
Abraham, L ;
Greendale, GA .
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2004, 26 (07) :955-969
[9]   White matter damage on diffusion tensor imaging correlates with age-related cognitive decline [J].
Charlton, RA ;
Barrick, TR ;
McIntyre, DJ ;
Shen, Y ;
O'Sullivan, M ;
Howe, FA ;
Clark, CA ;
Morris, RG ;
Markus, HS .
NEUROLOGY, 2006, 66 (02) :217-222
[10]   5-fluorouracil-induced leukoencephalopathy in patients with breast cancer [J].
Choi, SM ;
Lee, SH ;
Yang, YS ;
Kim, BC ;
Kim, MK ;
Cho, KH .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (03) :328-334